共 50 条
- [1] Pharmacokinetics and pharmacodynamics of GLP-1 agonist AVE0010 in type 2 diabetes patients[J]. DIABETES, 2008, 57 : A154 - A155Distiller, LarryRuus, Peter E.
- [2] Preclinical pharmacology of the new GLP-1 receptor agonist AVE0010[J]. ANNALES D ENDOCRINOLOGIE, 2008, 69 (02) : 164 - 165Werner, U.
- [3] Effect of the GLP-1 Agonist AVE0010 on Absorption of Concomitant Oral Drugs[J]. DIABETES, 2009, 58 : A132 - A132Liu, Yan-HongRuus, Peter
- [4] Effect of the GLP-1 receptor agonist AVE0010 on the absorption of concomitant oral drugs: acetaminophen and ethinylestradiol/levonorgestrel[J]. DIABETOLOGIA, 2009, 52 : S306 - S306Liu, Y. -H.Ruus, P.
- [5] AVE-0010 GLP-1 Receptor Agonist Treatment of Diabetes[J]. DRUGS OF THE FUTURE, 2008, 33 (10) : 838 - 840Campas, C.Castaner, R.
- [6] A dose-finding study of the new GLP-1 agonist AVE0010 in type 2 diabetes insufficiently controlled with metformin[J]. DIABETES, 2008, 57 : A129 - A129Ratner, Robert E.Rosenstock, JulioBoka, Gabor
- [7] Dose range effects of the new once daily GLP-1 receptor agonist AVE0010 added to metformin in type 2 diabetes[J]. DIABETOLOGIA, 2008, 51 : S66 - S66Rosenstock, J.Ratner, R. E.Boka, G.
- [8] Post-Meal Effects of AVE0010, a Once-Daily GLP-1 Receptor Agonist, in Type 2 Diabetes Inadequately Controlled on Metformin[J]. DIABETES, 2009, 58 : A151 - A152Rosenstock, JulioRatner, Robert E.Boka, GaborSilvestre, Louise
- [9] The GLP-1 receptor agonist AVE0010 abolishes OGTT-induced blood glucose excursion in healthy, normoglycemic dog without risk of hypoglycemia[J]. DIABETES, 2007, 56 : A129 - A130Werner, UlrichGerlach, ManfredHofmann, MichaelHerling, Andreas W.
- [10] Post-meal pharmacodynamic profile of AVE0010, a once-daily GLP-1 receptor agonist, in patients with type 2 diabetes inadequately controlled on metformin[J]. DIABETOLOGIA, 2009, 52 : S60 - S60Ratner, R. E.Rosenstock, J.Boka, G.Silvestre, L.